Toggle light / dark theme

NASA’s SpaceX CRS-35 mission to launch health research

NASA experiments focused on human and plant health and drug-resistant organisms will travel to the International Space Station aboard SpaceX’s 35th Commercial Resupply Services mission for the agency from Cape Canaveral Space Force Station in Florida, advancing research that benefits life on Earth and future exploration.

This research supports astronaut health during long-duration missions through four investigations from the agency’s Biological and Physical Sciences division, including 3D models of the human brain, a crop disease study, a faster way to assess astronaut health and an analysis of antibiotic-resistant bacteria aboard the space station.

Cannabinoid modulation of central amygdala population dynamics during threat investigation

Neural mechanisms underlying cannabinoids’ anxiogenic effects are not fully understood. Here authors show that cannabinoids dose-dependently increased spontaneous activity of central amygdala (CeA) neurons expressing somatostatin (SOM), altered CeA activity patterns during threat processing, and enhanced defensive behavior. Ex vivo studies in brain slices further showed that cannabinoids reduce inhibitory input from neighboring neurons, releasing a “brake” on SOM activity.

Could meditation reveal an SU(3) symmetry shared by the observer and the universe?

You sit down to meditate. A conversation returns, then thoughts. You bring your attention back to the breath. Sometimes, after many such returns, the effort eases. Thoughts lose their urgency, while awareness remains clear. Less occupies the mind, yet the moment still feels whole.

We are interested in what makes that wholeness possible. Even an ordinary moment brings together vision, memory, bodily sensation and attention. Their contents change constantly, but they belong to one experience. What physical organization allows the brain to hold them together, and what happens to that organization when experience itself appears to stop?

In our paper, “A Coherence–Dissipation Framework for Brain Dynamics and Consciousness,” published in the journal Entropy, we approach these questions through the quantum phenomenon of superconductivity, symmetry and the balance between coherence and dissipation. We propose a mathematical structure that could be sought in neural recordings, with meditation offering a setting in which to study how the relationship between activity and experience changes.

Genetic Risk for Anorexia May Begin Outside the Brain

While the investigators emphasize that PLIN4 variants were identified in a selected clinical subpopulation and require replication across larger, multi-ancestry cohorts, the identification of a peripheral fat-storage defect opens immediate avenues for drug discovery.

“Discovering genes that underlie this disease isn’t going to fix the disease,” Robison concluded. “But what it can do is teach us what’s causing the disease in lots of people, and we can use that information to design new treatments.”

The research team plans to analyze primary adipocyte tissue from anorexia patients carrying PLIN4 mutations to observe lipid droplet morphology and metabolic signaling directly, working toward therapies that can target peripheral lipid regulation alongside psychological rehabilitation.

Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases

Synaptic dysfunction and intracellular accumulation of pathological tau are convergent hallmarks of Alzheimer’s disease (AD) and related tauopathies, yet the molecular mechanisms coupling these events to widespread neurodegeneration remain incompletely understood. The Src family kinase Fyn has emerged as a critical signaling hub that integrates upstream pathogenic triggers, such as amyloid-β (Aβ), with downstream neurotoxic cascades. Here, we review the multifaceted roles of Fyn in orchestrating synaptic failure, highlighting how Fyn recruitment by mislocalized tau promotes N-methyl-D-aspartate receptor hyperactivation and calcium dysregulation. We examine the biophysical basis of Fyn–tau interactions, particularly the role of liquid–liquid phase separation in stabilizing toxic signaling complexes. We also discuss how aberrant Fyn signaling in microglia and astrocytes amplifies neuroinflammation. Finally, we evaluate the potential of Fyn as a therapeutic target, emphasizing the necessity of strategies that selectively uncouple pathological signaling from physiological functions to effectively halt disease progression.

Scientists just gave the powerhouses of our cells a high-tech upgrade

Scientists have developed a way to coat mitochondria, the tiny structures that produce energy inside our cells, with advanced materials without interfering with their function. The achievement could eventually help researchers develop new approaches to treating diseases caused by malfunctioning mitochondria.

The research was conducted by IRCCS Fondazione Istituto Neurologico Carlo Besta (FINCB) and Politecnico di Milano through their joint BraiNs laboratory, established in 2023. The collaboration combines the mitochondrial biology expertise of Dr. Valeria Tiranti (FINCB), a researcher in the Medical Genetics and Neurogenetics Complex Unit (SC) and head of the Fondazione Mariani Centre for Paediatric Mitochondrial Diseases, with the chemistry and materials engineering expertise of Professor Pierangelo Metrangolo (Politecnico di Milano).

A planetarium for the brain

An important innovation for communication of neuroscience to the public! “Sloan’s planetarium film premiered during the weeklong BrainFest event in Seattle in March… Sloan says he plans to make the film freely available and hopes it will eventually be shown at planetariums around the world.”


Neuroscientists should take a cue from astrophysicists and use planetariums to inspire awe, argues Tyler Sloan. His new film takes a first step.

Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapy

Ependymoma accounts for 6.7% of all pediatric brain tumors, the majority of which occur in patients under 5 years of age. Though chemotherapeutic regimens have been employed with some benefit, the general frontline treatment strategy for localized disease includes maximal safe surgical resection followed by adjuvant focal radiotherapy (RT). Ependymomas can arise anywhere in the brain or spine, but the majority occur in the posterior fossa near the brainstem and other important cranial nerves and structures. Tumor location and the young age of patients pose technical challenges in achieving local control while minimizing late effects of treatment.

Proton radiotherapy (PRT) is a form of particle radiation that has unique properties which allow for conformal delivery of radiation dose to the target with reduced dose to surrounding normal structures. This reduced radiation exposure to healthy tissues should minimize the incidence and severity of late adverse side effects, which can negatively impact the quality of life of childhood cancer survivors., We have previously published early clinical outcomes of 70 pediatric patients with ependymoma who were treated with PRT at our institution. In this study, we report mature clinical outcomes in a large proton treated cohort—including disease control outcomes, patterns of failure, the incidence of neurologic injury and secondary malignancies, and the effects of clinical variables on outcomes.